期刊文献+

HPV分型检测对宫颈细胞学阴性妇女的诊断价值研究 被引量:8

Diagnostic Values of HPV Subtype Testing on Women with Negative Cervical Cytology
原文传递
导出
摘要 目的探讨高危型HPV分型检测对宫颈细胞学阴性妇女的宫颈病变诊断价值。方法对宫颈细胞学阴性、HPV阳性的妇女436例进行阴道镜检查。根据不同年龄组及不同高危型HPV型别,分为HPV 16/18阳性组,其余HR-HPV阳性组,分析年龄和高危型HPV型别与重度宫颈病变的关系。结果 436例女性中,30~39岁、40~49岁和≥50岁年龄组CIN II+的患病风险分别是<30岁年龄组妇女的2.1、1.5和1.7倍。HPV 16/18型阳性CIN II+患病风险是其余HR-HPV阳性的3.3倍,两组患病率分别为21.59%和7.62%,差异有统计学意义(P<0.01)。结论 HPV分型检测对细胞学阴性妇女的宫颈病变有重要诊断价值。宫颈细胞学阴性、HPV 16/18阳性,建议行阴道镜检查,尤其是年龄≥30岁妇女,有更重要意义。 Objective To explore the diagnosis values of HPV subtype testing on women with negative cervical cytology. Methods 436 women with positive HPV and negative cytology results were enrolled. Subjects were divided into four groups, including 〈 30, 30 - 39, 40 -49 and,≥ 50 year old groups. According to HR - HPV genotyping, the subjects were divided into HPV 16/18 positive group and HR - HPV - positive group. Results The prevalence of CIN Ⅱ + of HPV HPV 16/18 positive group and HR - HPV positive group was 21.59% and 7. 62% respectively. There was significant difference between the two groups ( P 〈 0. 01 ). The odds ratios of CIN Ⅱ + of 30 - 39, 40 -49, ≥50 years old groups were 2. 1, 1.5 and 1.7 times of 〈30 age group respectively. The odds ratio of CIN Ⅱ + of HPV 16/18 positive group was 3.3 times of HR - HPV positive group. Conclusion HPV genotyping has important diagnostic value for cervical lesions with cytology -negative women, especially when the women was more than 30 years old with HPV 16/18 positive.
出处 《浙江预防医学》 2012年第9期4-6,16,共4页 Zhejiang Journal of Preventive Medicine
关键词 宫颈癌 宫颈上皮内瘤变 年龄 HPV分型 Cervical lesion Cervical intraepithelial neoplasia Age HPV genotyping
  • 相关文献

参考文献7

  • 1Smith JS,Lindsay L,Hoots B,et al.Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions:a meta-analysis update[J].Int J Cancer,2007,121(3):621-632.
  • 2Marie-Hélène Mayrand,Eliane Duarte-Franco,Isabel Rodrigues,et al.Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer[J].N Engl J Med,2007,357(16):1579-1588.
  • 3Franco EL,Ferenczy A.Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination[J].Vaccine,2007,3(3):319-327.
  • 4Sideri M,Igidbashian S,Boveri S,et al.Age distribution of HPV genotypes in cervical intraepithelial neoplasia[J].Gynecologic Oncology,2011,121(3):510-513.
  • 5Winer RL,Kiviat NB,Hughes JP,et al.Development and duration of human papillomavirus lesions,after initial infection[J].J Infect Dis,2005,191(5):731-738.
  • 6Herrero R,Castell sague X,Pawlita M,et al.Human papillomavirus and oral cancer:the international Agency for Research on Cancer multicenter study[J].J Natl Cancer Inst,2003,95(23):1772-1783.
  • 7Zhao C,Chen X,Onisko A,et al.Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results[J].Gynecologic Oncology,2011,122(2):291-296.

同被引文献89

  • 1王玲.第二代杂交捕获法检测宫颈人乳头瘤病毒感染的初步研究[J].中国临床医学,2005,12(6):1061-1062. 被引量:7
  • 2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010,127 (12) : 2893-2917.
  • 3Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract[J]. Infect Dis Obstet Gynecol, 2006,14 (Suppl) : 105-109.
  • 4Trottier H, Franco EL. The epidemiology of genial human pap- illoma virus infection[J]. Vaccine, 2006,24(Suppl 1) : 1-15.
  • 5Spano JP,Nareelin AG, Carcelin G. HPV and Cancer[J]. Bull Cancer,2005,92(1) : 59-64.
  • 6Ganguly N, Parihar SP. Human papilloma virus E6 and E7 oncoproteins as risk factors for tumorigenesis[J]. J Biosci,2009,34(1) 113-123.
  • 7Clifford GM, Smith JS,Plummer M,et al. Human papillo- mavirus types in invasive cervical Cancer worldwide., a meta-analysis[J]. Br J Cancer, 2003,88 (1) : 63-73.
  • 8An HJ ,Cho NH, Lee SY, et al. Correlation of cervical carci- noma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip mi- croarray method[J]. Cancer, 2003,97(7) : 1672-1680.
  • 9Sideri M, Igidbashian S, Boveri S, et al. Age distribution of HPV genotypes in cervical intraepithelial neoplasia[J]. Gynecol Oncol, 2011,121 (3) : 510-513.
  • 10Brummer O, Hollwitz B, Bohmer G, et al. Human papillo- mavirus-type persistence patterns predict the clinical out- come of cervical intraepithelial neoplasia [ J ]. Gynecol Onco1,2006,102 ( 3 ) : 517-522.

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部